Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,289–3,296 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Pfizer Inc. Modified RNA (modRNA) vaccine Influenza Phase 2 Data Released Intramuscular Antiviral
Pfizer Inc. Danuglipron (PF-06882961) - (PK Study) Obesity Phase 2 Trial Discontinued Oral Endocrinology
Pfizer Inc. Lotiglipron (PF-07081532) Obesity and Type 2 diabetes mellitus (T2DM) Phase 2 Oral Endocrinology
Pfizer Inc. ORIC-533 and elranatamab Multiple myeloma Phase 2 Enrollment Conclusion ORIC-533 oral elranatamab subcutaneous Oncology
Pfizer Inc. PF-06760805 (GBS6) Streptococcus Vaccine Phase 2 Intramuscular Immunology
Pfizer Inc. MRx0518 with bavencio (avelumab) 1L Urothelial carcinoma Phase 2 Intravenous Oncology
Pfizer Inc. BNT162b5 COVID-19 vaccine Phase 2 Intramuscular COVID-19
Pfizer Inc. Ervogastat (PF-06865571) and clesacostat (PF-05221304) Metabolic dysfunction-associated steatohepatitis (MASH) with liver fibrosis Phase 2 Oral Gastroenterology